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TOPIC : A STUDY ON SERUM ANTICARDIOLIPIN ANTIBODY IN 
PSEUDOEXFOLIATION. 
ABSTRACT:    
AIM: 
1)  To evaluate the levels of anticardiolipin antibodies in patients with 
pseudoexfoliation and controls. 
 2) To assess the association between pseudoexfoliation and cardiovascular 
disease. 
MATERIAL AND METHODS: This   is a  prospective study to  evaluate the 
levels of anticardiolipin antibody in patients with pseudoexfoliation. This study 
included 30 patients with pseudoexfoliation and 30 healthly controls with 
comparable age and gender with no comorbities.  
All patients underwent a complete ophthalmic examination , after  
pseudoexfoliation was diagnosed. Echocardiography was done to know the 
cardiovascular status of the patients in 2 groups. 
 Serum  anticardiolipin  antibodies IgG and IgM was done by using ELISA method 
in both cases and control groups. 
 
 
 
 Results: 
 We found elevated serum levels of anticardiolipin (IgG and IgM) antibody in 
patients with pseudoexfoliation. The mean level of acl IgG and IgM level in  
patients with pseudoexfoliation were statistically significant(p value<0.05). 
 
Conclusions: 
Elevated levels of anticardiolipin antibody is a risk factor for cardiovascular 
problems . Hence the attending ophthalmologist will be able to intimate the 
attending physician about the possible cardiac  risk association. 
KEY WORDS: Pseudoexfoliation, True efoliation, Anticardiolipin antibody, 
endothelial dysfunction. 
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INTRODUCTION: 
Pseudoexfoliation is characterised by the widespread deposition of whitish flaky   
material adherent to the ocular and extraocular tissues. Among the extraocular 
tissues,  pseudoexfoliative  fibres   are seen in heart, lungs, skin, gallbladder, 
blood vessels.  In  present years pseudoexfoliation  has  been shown to be a 
systemic process   associated  with  cardiovascular  disease. 
Since its discovery pseudoexfoliation syndrome has undergone extensive 
research for its unique  distribution  and pathological changes in the eye. 
Being more common in elderly it causes a variety of ocular and systemic 
manifestations. These patients are at higher risk of developing glaucoma, 
corneal endothelial cell loss, sphincter atrophy of the iris , poor mydriasis, iris 
neovascularization , transillumination defects, zonular dialysis and spontaneous 
dislocation of lens. 
Studies suggested a vascular endothelial involvement seen in pseudoexfoliation.  
Vascular occlusions has also been common in patients with pseudoexfoliation. 
Endothelial dysfunction has an important contributory  role. 
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Antiphospholipids are immunoglobulins belonging to a group of autoantibodies 
directed against phospholipids & phospholipid protein complex in all 
membranes. The presence of high level of antiphospholipids  has been 
associated with  various systemic thromboembolic  and ophthalmic conditions 
such as anterior ischemic optic neuropathy, amaurosis fugax and  retinal and 
choroidal vascular occlusions. Anticardiolipin and lupus anticoagulant are 
together referred to as antiphospholipid antibodies. Lupus anticoagulant 
antibodies  are mainly to detect systemic lupus erythematous. Pseudoexfoliation 
and  anticardiolipin antibodies share a  common associations in various ocular 
and systemic conditions. We therefore aim to evaluate the levels of 
anticardiolipin antibodies in patients with pseudoexfoliation and in controls. 
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REVIEW OF LITERATURE: 
In 1917, Lindberg  was the first person to describe pseudoexfoliation. 
Exfoliation is the most common identifiable cause of open angle glaucoma 
worldwide and called as pseudoexfoliative glaucoma (PXG). It is a systemic 
disorder with important eye manifestations including development of open and 
closed angle glaucoma, cataract with zonular instability . Pseudoexfoliation is 
more common in  older age groups, with most occurring in the late 60s and 
early 70s.The condition may be unilateral or bilateral. It is more prevalent in the 
Scandinavian countries. 
It has been estimated that  more than  60 to 70 million people in the  world are 
affected  and the  risk of glaucoma increases 5% at 5 years  and 15% at 10 years  
. The prevalence of pseudoexfoliation increases steadily with age in all 
populations. About two third of patients have clinically unilateral involvement, 
and subsequently showed bilateral involvement later in life .It can be diagnosed 
prior to the clinically visible appearance of exfoliative material by conjunctival 
biopsy, showing that the disease is present microscopically even before it is 
detected clinically in the fellow eye. 
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True exfoliation 
In capsular delamination, superficial layer of lens capsule separate from the 
deeper layers  to from scroll like margins  and floats  in the anterior chamber as 
thin , clear membrane. 
Elschnig first described capsular delamination as glass blower cataract and 
subsequently found that exposure to infrared radiation was responsible for it. 
Capsular delamination is uncommon, because of the widespread use of 
protective goggles by the exposed workers. Glaucoma is not a common feature 
in true exfoliation 
 
 
Pseudoexfoliation syndrome (PXS) is characterized by the widespread 
deposition of whitish flaky material on many ocular and extraocular tissues. 
Other terms used are senile exfoliation syndrome, glaucoma senilis, complex 
pigmentory glaucoma, exfoliation of the pseudocapsule and senile uveal 
exfoliation. Exfoliation material is produced by basement membrane of all 
tissues and is composed of microfibrils such as elastin, tropoelastin, amyloid P, 
proteoglycan and transforming growth factor. Exfoliative  material is seen in  
many cell types in anterior segment including conjunctiva, lens capsule 
epithelium, corneal endothelium and Schlemn canal endothelium. Extra ocular 
sites are extra ocular muscles, orbital septa, posterior ciliary arteries, vortex 
veins and central retinal vessels. Being a systemic disorder it has also been 
16 
 
demonstrated in tissues throughout the body like lungs, heart, liver, gall bladder, 
skin, kidney and cerebral meninges, suggesting a systemic process involving 
generalized abnormal elastin metabolism. Histologically pseudoexfoliative 
material has been demonstrated in aorta and peripheral arteries 8.  
 
ETIOLOGY AND PATHOGENESIS: 
 
 Genetic basis responsible for PXF include familial aggregation , transmission 
in two generation families, higher concordance rates in monozygous twins, 
relatives of affected patients. Recently LOX1 gene is  responsible for formation 
of elastic fibres in Pseudoexfoliation.  However, a number of non genetic 
factors  are also responsible for exfoliative material which includes dietary 
factors, autoimmunity, infectious agents and trauma. These factors has been 
hypothesized , but have not been proven2. 
Altogether, Pseudoexfoliation represents a complex, multifactorial, late onset 
disease with genetic and nongenetic factors involved  in  the  pathogenesis. 
The key pathogenetic factors involved are microfibrillopathy involving 
transforming growth factor-1, oxidative stress and impaired cellular protection 
mechanism. 
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Current concepts of the pathogenesis of exfoliation syndrome 
1) LOX1 gene plays an important role in modifying tropoelastin, the basic 
building block of elastin and  cause protein aggregation leading to accumulation 
of elastotic exfoliation material. 
 2) Oxidative stress induced elastosis, an elastic microfibrillopathy associated 
with the excessive production of elastic microfibrils leads to increased matrix 
synthesis. 
3) Imbalance between matrix metalloproteinase and transforming growth factor 
beta 1 will cause aggregation, cross linkage, increased matrix degradation 
leading to matrix accumulation in pseudoexfoliation1. 
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Figure 1: Exfoliation syndrome pathogenesis 
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CORNEAL CHANGES 
Flakes of exfoliative material and pigment accumulation can be seen on the 
corneal endothelium scattered diffusely or in the form of a vertical spindle 
similar to the Krukenberg spindle in pigment dispersion syndrome. Specular 
microscopy of corneal endothelium  has revealed a lower cell density in 
pseudoexfoliation eyes and found that exfoliative material was formed by 
degenerative endothelial cells. It has also been suggested that corneal 
endotheliopathy in patients with exfoliation syndrome can give rise to guttate 
appearance1. 
 
LENS, ZONULE, CILIARY BODY CHANGES 
The characteristic appearance of exfoliative material on the anterior lens capsule 
has three distinct zones.  
Zone.1 is a translucent central disc with occasional curled edges,   
Zone-2 is a clear zone corresponding to contact with the moving iris and  
 Zone-3  is a peripheral granular zone.  
 Nuclear cataract occurs frequently in eyes with exfoliative syndrome. However 
studies found no association between cataract and exfoliation. Involvement of 
the zonules can lead to lens subluxation and phacodonesis. This  instability of 
the zonules are due to deposition of exfoliative material on the zonules between 
non pigmented ciliary epithelial cells and at the preequatorial region of the lens. 
20 
 
Proteolytic enzymes in the exfoliative material may facilitate zonular 
disintegration. These alterations can lead to lens subluxation and phacodonesis.  
During cataract surgery  patients with pseudoexfoliation are prone to have many 
complications like iridodialysis, poor mydriasis, vitreous loss and post operative 
complications  like  decentration of intraocular lenses , capsule contraction 
syndrome and posterior capsular opacification1. 
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FIGURE 2: Exfoliation syndrome is demonstrated by three distinct zones on the 
anterior lens capsule Zone-1-A translucent central disc with occasional curled 
edges,  Zone-2 a clear zone corresponding to contact with the moving iris and  
Zone-3 a peripheral granular zone.  
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Figure 3: Exfoliation material - Based on the morphologic alterations of the 
anterior lens capsule. 
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Figure 4: EXFOLIATION SYNDROME ZONULOPATHY. A: Scanning 
electron micrograph shows an accumulation of exfoliation material  in the 
region of   the ciliary process. B: Exfoliation syndrome created zonular tension  
during  surgery so that the posterior capsule tension is flaccid, which makes 
incomplete cortex removal .  
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Figure 5: Uneven or disrupted zonules with 
peripheral lens accumulation of exfoliative 
material B: patchy deposits on zonules 
characteristic of exfoliation syndrome. 
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IRIS CHANGES 
Pseudoexfoliative material is also seen as white flecks on the pupillary margin 
of the iris, with loss of pigment at the pupillary ruff. Iris transillumiation 
typically reveals a moth eaten pattern near the pupillary sphincter. 
Ultrastructural studies suggest that hypoperfusion due to abnormal extracellular 
matrix is a contributory factor in the development of pseudoexfoliation 
syndrome. Subsequently atrophy of the pigment epithelium,  and dilator muscle 
cells account for the poor mydriasis which is also typical finding in   
pseudoexfoliation1. 
  
Figure 6: Exfoliative material at pupil border 
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GONIOSCOPIC  FINDINGS 
The pseudoexfoliation is associated with excessive pigment dispersion, leading 
to increased trabecular meshwork pigmentation. The pigmentation seen in 
pseudoexfoliation is uneven than that seen in pigmentary glaucoma. Iris scrapes 
the exfoliation material on the anterior lens surface which causes the  release of  
pigment epithelial cells in iris with concomitant  dispersion of pigments into the 
anterior chamber which leads to loss of pupillary ruff, iris sphincter 
transillumination and  increased trabecular pigmentation. Pigments  are also 
seen along  the Schwalbe’s  line  and   termed as Sampaolesi line. 
Ultrastructural studies suggest that  progressive accumulation of exfoliative 
material in angles leads to swelling  and disorganization of juxtacanalicular 
meshwork  and gradual narrowing of the schlemn canal. 
Anterior chamber depth was found to be normal in most eyes in 
pseudoexfoliation syndrome1. 
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Figure 7: Gonioscopic view of an eye with exfoliation syndrome shows 
irregular pigmentation of trabecular meshwork and white flecks of exfoliative 
material. 
 
 
 
COURSE OF GLAUCOMA 
 The risk of glaucoma increases 5% at 5 years  and 15% at 10 years in patients 
with pseudoexfoliation.  The incidence of glaucoma in exfoliation syndrome is 
around 22  to 49%. According to the Early Manifest Glaucoma Trial (EMGT) 
patients with ocular hypertension and exfoliation syndrome were at twice a risk 
of conversion to glaucoma when compared with age matched controls without 
pseudoexfoliation2.   
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 Mechanism of Open angle glaucoma  
Most eyes with pseudoexfoliative glaucoma have an open angle mechanism , 
although acute angle closure glaucoma also occurs in an small  number of cases. 
The gene responsible for glaucoma in pseudoexfoliation is LOXL 1 gene. 
Mechanism of intraocular pressure elevation in glaucoma are  due to passive 
deposition of exfoliative  material and endothelial damage  in  the trabecular 
meshwork  which leads to increased  resistance to aqueous outflow1. 
ANGLE CLOSURE GLAUCOMA  
 A less common mechanism of acute or chronic  angle closure glaucoma are due 
to pupillary block including zonular weakness causing anterior movement of the 
lens, increased adhesiveness of the iris to the lens due to exfoliative material, 
sphincter muscle degeneration, uveitis and iris rigidity  due to hypoxia1. 
ACUTE INCREASES IN INTRAOCULAR PRESSURE 
Patients with open angles and exfoliation syndrome may present with acute 
angle angle closure glaucoma1.  
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 Figure 8: Schematic  diagram of the trabecular meshwork shows localization of 
exfoliation  material  in   endotrabecular and exotrabecular  meshwork. 
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                   PATHOGENESIS OF PSEUDOEXFOLIATIVE GLAUCOMA           
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OCULAR ASSOCIATIONS 
Exfoliation syndrome is associated with ocular and systemic vascular 
abnormalities. Retinal vein occlusion has been associated with PEX. In a 
retrospective study  73 eyes of 70 patients with branch retinal vein occlusion   
(BRVO), 53 eyes of 49 patients with central retinal vein occlusion (CRVO) 
were studied. Pseudoexfoliation was present in 6 of 73 eyes (8.2% BRVO), 11 
of 53 eyes with central retinal vein occlusion (20.8%) and 20 of 384 age 
matched controls (5.2%). 
  
Possible mechanism of central retinal vein occlusion in Pseudoexfoliation: 
 
1) Involvement of the retinal vasculature  by the pseudoexfoliative process leads 
to hypoperfusion that can lead to thrombosis of central retinal vein3. 
Cursiefen et al ,reviewed the records of 332 patients with branch retinal vein 
occlusion and 159 patients with central retinal vein occlusion for the presence of 
pseudoexfoliation syndrome. The PXS was seen in 20% of patients with branch 
retinal vein occlusion and 27% in central retinal vein thrombosis.  Venous 
thrombosis could be a causative risk factor for retinal vein thrombosis in 
pseudoexfoliation 4. 
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STUDIES SHOWING SYSTEMIC ASSOCIATIONS  IN 
PSEUDOEXFOLIATION. 
 
Patients with pseudoexfoliation had increase chances of decrease in blood flow 
velocities in  meningeal artery, carotid artery, ophthalmic artery,  and central 
retinal artery,  leading to cardiovascular and cerebrovascular disease 5. 
Recently higher Homocysteine concentration in aqueous, tear fluid and plasma  
has been documentated  in PEX patients6.   
 Tranchina L et al screened 36 patients with PEXS, 40  with primary open 
angle glaucoma(POAG) and 40 age matched controls. Plasma 
Homocysteine concentrations, serum vitamin B12 and folic acid  levels 
analysed by competitive chemiluminescent enzyme immunoassay were 
done for these patients. The plasma homocysteine levels exceeding 14 
ml/l were considered elevated. They reported  that ,plasma homocysteine 
was significantly higher in PXG compared with POAG and controls and 
concluded  that hyperhomocysteinemia can be an independent risk factor 
for vasculopathy in  pseudoexfoliation patients6. 
 Lovro Bojic  et al studied 21 patients with PEX glaucoma and 24 controls 
. Two dimensional and pulsed Doppler echocardiography was performed 
. 21 patients had reduced diastolic filling parameters i.e Ejection fraction 
(EF), ventricular filling during diastole, velocity time integral E wave and 
A wave. However systolic function  of EF and fractional shortening were 
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not statistically significant between  pseudoexfoliative glaucoma and the 
controls. The presence of  pseudoexfoliative material in the myocardial 
cells and basement membrane causes prolonged relaxation of left 
ventricle 7. 
 Pinar Tuna et al conducted a prospective study of 23 patients with 
pseudoexfoliation syndrome and 20 healthy  age matched controls. Out of 
23 patients, 11 patients had pseudoexfoliative glaucoma. Patients who 
had a history of myocardial infarction, angina pectoris, left ventricular 
dysfunction, heart failure, stroke, cerebrovascular disease, current 
smoking, diabetes mellitus were excluded from the study. All patients 
subjected to transthoracic echocardiography to evaluate left ventricular 
function and left ventricular wall thickness using a 2-4 MHz phased –
array scanner. 
 Arterial  endothelial function of the brachial artery was assessed by  
brachial artery ultrasound after a 12 hour fasting  and resting of  15 
minutes . Vascular response to reactive hyperemia (flow mediated 
dilation) and sublingual nitroglycerin (NTG mediated dilation) were 
measured. 
Endothelial dependent FMD and NTG mediated dilation were 
significantly lower in the pseudoexfoliation than in control groups8 . 
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This study suggest that presence of pseudoexfoliative material in the 
adventitial and subendothelial connective tissuse leads to  arterial 
endothelial dysfunction and  lower vascular response in arterial system8.  
 
TREATMENT OPTIONS 
Glaucoma associated with exfoliation syndrome can be particularly challenging 
to manage. Care should be taken while setting the target pressure because intra 
ocular pressure can fluctuate. 
The sole focus of therapy in PEX should not be the reduction of intraocular 
pressure. The initial approach to medical therapy of PEX  has been similar to 
that of POAG. Pseudoexfoliatiove glaucoma is more difficult and resistant to 
treat as compared to primary open angle glaucoma. Medical therapy includes 
topical prostaglandins analogues (Bimatoprost, Latanoprost and Travoprost) and 
aqueous suppressants2. 
Excellent response has been reported  for  prostaglandin analogues and laser 
trabeculoplasty. 
In recent crossover trial comparing Latanoprost to Bimatoprost  , Bimatoprost 
has 35% reduction and 31% reduction in Latanoprost. In another 24 hour study 
Travoprost provided a slightly greater hypotensive effect than Latanoprost. 
Konstas et al demonstrated that the reduction of 17 mmHg target  intra ocular 
pressure ( IOP)  is necessary to prevent progressive damage2. 
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Aqueous suppressants may lower IOP but do not interfere much with the  
progression of trabecular damage. 
Cholinergic agents have multiple beneficial actions in pseudoexfoliation  by 
increasing aqueous outflow thereby  clearing  the trabecular meshwork . 
Theoritically,  miotics should be the first line of treatment2. 
An international, multicentric institutional prospective trial (ICEST) is currently 
comparing latanoprost and 2% pilocarpine versus timolol and 
cosopt(Dorzolamide and timolol) for patients with Pseudoexfoliation and ocular 
hypertension or glaucoma2. 
Because of the strong association with elevated homocysteine levels one must 
also consider, supplementing vitamins B6, B12 and folic acid in patients with 
pseudoexfoliation6. 
 
LASER THERAPY 
Argon laser trabeculoplasty  (ALT) is useful if baseline IOP  is higher than in 
eyes with Primary open angle glaucoma. ALT can delay the use of medical 
therapy for upto 8 years. A  gradual reduction in success rate  is also noted 2 
 
SURGICAL THERAPY 
In recent study trabeculectomy with mitomycin C obtained better 24 hours IOP 
control in advanced PEX and POAG. However surgical complications are more 
common in PEX  patients1. 
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Cataract and Pseudoexfoliation  
*Poor pupillary dilatation and occasional posterior  synechiae 
* Preoperatively zonular dialysis , phacodonesis, reduced endothelial cell 
density 
PRATICAL TIPS DURING CATARACT SURGERY  
* Large capsulorrhexis should be made  to minimize zonular stress,  and also to  
prevent phimosis.  
*During hydrodissection tap the center of the nucleus to decompress the fluid 
pressure on a weak posterior capsule. 
*If zonular weakness is present  capsular tension ring is used  intraoperatively1. 
Differential diagnosis: 
The exfoliation syndrome must be differentiated from other forms of lens 
exfoliation 
• Capsular delamination 
• Primary amyloidosis 
• Pigment dispersion 
Pigment Dispersion 
Pigment granules are dispersed throughout the anterior segment but is  seen 
primarily on the cornea and iris. Iris transillumination is a valuable diagnostic 
feature of pigmentary glaucoma. The characteristic appearance is a radial stroke 
like pattern in the mid periphery of the iris. 
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Primary Amyloidosis 
This is a generalised , systemic disorder  which may be familial or nonfamilial. 
The amyloid may be deposited as a white flaky substance in pupillary margin of 
the iris, anterior lens capsule and the anterior chamber angle creating a clinical 
picture that resembles the exfoliation syndrome. 
 
 
Capsular delamination 
True exfoliation differs  from  pseudoexfoliaton by  the underlying precipitating 
factor such as uveitis, exposure to intense heat and trauma. It has  a thin, clear 
membrane separating  from the anterior lens capsule, which  often curls at the 
margins. Glaucoma occurs infrequently with capsular delamination.  
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                                      ANTIPHOSPHOLIPID ANTIBODY 
Antiphospholipid antibodies (APL) are immunoglobulins, belonging to a group 
of a heterogenous autoantibodies directed against phospholipids complexes 
which are the main constituents of all membranes. These antibodies are 
anticardiolipin, lupus anticoagulant and anti β2  glycoprotein.  Antiphospholipid 
antibody is tested by using solid phase ELISA assays (anticardiolipin 
antibodies) and liquid phase coagulation assays (lupus anticoagulant). Normal 
value of anticardiolipin antibody  immunoglobulin G and M are 12Gpl-u/ml
  
and 
12Mpl-u/ml4. A combination of two positive tests in two separate occasions at 
least 6 weeks apart is usually required to confirm the diagnosis. 
 
 Antiphopholipid antibody has been found in arterial and venous thrombosis, 
SLE, thrombocytopenia and recurrent abortion. If it is present in the absence of 
any of these disorders  it known as the primary antiphospholipid antibody 
syndrome9 . 
The Antiphospholipid syndrome is one of the most common risk factor for 
thrombosis. It results from formation of antibodies that are directed against beta 
2 glycoprotein or other  phospholipid binding protein such as prothrombin, 
protein S and thrombomodulin.  
The term antiphospholipid was first demonstrated ,when it reacted with antigens 
in patients with syphilis and was detected by Wasserman reaction and VDRL. 
Later, IgG and IgM  were demonstrated in the lupus anticoagulant  which 
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reacted with the phospholipid portion of the prothrombin converting complex in 
the coagulation cascade to cause prolongation of activated partial 
thromboplastin time10. 
It was recently considered that the lupus anticoagulant and anticardiolipin 
antibodies  are collectively referred as antiphospholipid antibodies10. 
IgG antiphospholipid was commonly associated with various ocular and 
vascular occlusions. 
 
OPHTHALMIC FEATURES AND ANTIPHOSPHOLIPID ANTIBODY 
The prevalance of vascular occlusive features in patients with positive 
antiphospholipid antibodies was 33%. However Giordano suggested that 
antiphospholipid  antibodies have no role in ocular vascular occlusion11. 
 
OCULAR MANIFESTATIONS   
ANTERIOR SEGMENT FINDINGS 
Conjunctival telangectasia 
Episcleritis 
Scleritis 
Dry eyes 
Iris rubeosis 
POSTERIOR SEGMENT FINDINGS 
Venous stasis retinopathy 
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Venous tortuosity 
Cotton wool spots 
Retinal hemorrhages 
Retinal edema 
Retinal vein occlusion 
Retinal artery occlusion 
Optic neuropathy 
Vitreous hemorrhage 
Retinal neovascularisation 
Vasculitis 
NEURO OPHTHALMOLOGICAL MANIFESTATIONS 
Transient visual obscurations 
Amaurosis fugax 
   
Etiology of APLA 
 Apoptosis , a programmed cell death has recently been reported in the 
etiological  mechanisms in  antiphospholipid antibody syndrome. 
Endothelial cell activation is induced by thrombotic factors like production of 
nitric oxide, prostacyclin, tissue plasminogen activation, platelet activation and 
heparin like prostaglycan. R Del Papa et al strongly suggests  that APL 
antibodies  will bind with endothelial cells of beta 2 glycoprotein -1 resulting in  
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increased adhesiveness of leukocytes, platelets  and diminished heparin- 
antithrombin III function  leading  to thrombosis.  
Endothelial dysfunction play an important role in the development of 
thrombosis in Antiphospholipid antibody syndrome10.  
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 Figure 9: Pathogenesis of Antiphopholipid antibody 
 
 
 
 
 
  
43 
 
 Laboratory approach to antiphospholipid antibody detection 
 Testing stage   and     Method of detection  
Initial testing: The first step is prolongation of coagulation in atleast one 
phospholipid dependent in vitro coagulation assays  with the  use of platelet 
poor plasma. These assays can be subdivided  according to the portion of the 
coagulation cascade. 
 The extrinsic coagulation pathway  
 The intrinsic coagulation pathway 
 The final common coagulation pathway 
 
Mixing:  The second step is a feature to correct the prolonged coagulation time 
by mixing the patients plasma with normal plasma. 
Correction/ Neutralisation:   The third step is confirmation of the presence of 
lupus anticoagulant antibodies by shortening or correction of the prolonged 
coagulation time after the addition of excess phosholipid or platelets that have 
been frozen and the thawed. 
Exclusion: The fourth step is ruling out other coagulapathies with the use of 
specify factor assay if the confirmatory test is regulation or if a specific factor 
inhibition is suspected.      
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NEED FOR THIS STUDY: 
Elevated  Antiphospholipid antibody level is a risk factor for  various systemic 
and ocular disease. Ocular conditions like retinal vein occlusions, retinal 
neovascularisation, amaurosis fugax, ischemic optic neuropathy and systemic 
conditions like myocardial infarction, coronary ischemia and pulmonary 
embolism. Endothelial dysfunction is an important contributory role in 
anticardiolipin antibodies. 
Being a systemic disease,  it can be identified in many extraocular structures 
such as heart, blood vessels, optic nerve, cerebral meninges and associated with  
stroke, asymptomatic myocardial dysfunction and systemic endothelial 
dysfunction .  
 Pseudoexfoliative material in myocardium causes the dysfunction of 
endothelium    which leads to increased cardiovascular risk in patients with 
pseudoexfoliation. When  anticardiolipin antibodies bind to beta 2 glycoprotein 
in cell wall, endothelial dysfunction occurs, resulting in reduced heparin anti-
thrombin III function, increased platelet activation and  finally thrombosis.  
We used anticardiolipin antibodies as  an independent marker to elucidate  the  
function of cardiovascular system. 
 So we evaluated the levels of anticardiolipin antibodies in patients with 
Pseudoexfoliation and in  controls.  Hence the attending ophthalmologist will be 
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able to intimate the attending physician about the possible cardiac  risk 
association. 
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PART-2 
AIMS  OF THE STUDY 
PRIMARY AIM: 
1)  To evaluate the levels of anticardiolipin antibodies in patients with 
pseudoexfoliation and controls. 
 2) To assess the association between pseudoexfoliation and cardiovascular 
disease. 
Secondary Objective 
 1) To study the ocular diseases  associated with pseudoexfoliation. 
          2) To correlate between ocular diseases and anticardiolipin antibody. 
INCLUSION CRITERIA: 
 Patients with Pseudoexfoliation 
EXCLUSION CRITERIA:   
1) History of diabetes and hypertension         
2) History of Bleeding disorders 
 3)History of long term use of diverse drugs like antiseizures drugs (phenytoin), 
antibiotics (amoxicillin) and  hydralazine. 
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MATERIALS AND METHODS: 
 This study includes 30 patients with pseudoexfoliation and 30 healthly 
controls in comparable age group and gender who attended the 
ophthalmology  department in PSG  during 2 years period. 
  Patients with  known case  of cardiovascular disease like myocardial 
infarction, stroke, diabetes, hypertension ,bleeding disorders, long term 
use of diverse drugs like antiseizures drugs (phenytoin), 
antibiotics(amoxicillin) and hydralazine were excluded from the study 
because these disorders will elevate the anticardiolipin level in the blood.  
 All patients underwent  a complete ophthalmic examination including 
best corrected visual acuity, slit lamp examination, intraocular pressure 
by Applanation tonometry, angles by three mirror  Goldmann 
goniolenses,  and dilated   fundus examination. 
 PXS was diagnosed if slit lamp examination showed presence of 
Pseudoexfoliation material at the pupillary border , anterior lens capsule  
and Sampaolesi line on gonioscopy. 
 Controls were matched to cases by age, sex  to make the groups 
maximally comparable. 
 Echocardiography was done to know the cardiovascular status of the 
patients in 2 groups. 
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 Serum Anticardiolipin   antibodies will be estimated by using ELISA 
method in both cases and control groups. 
 ANTICARDIOLIPIN ANTIBODY:  
3ml  of Venous blood samples were obtained. Anticardiolipin antibodies  
            (IgG  and IgM) were measured by enzyme-linked  immunosorbent 
assay.  
      IgM and IgG results were classified as positive(>12 GPL/Ml)  
      or negative    (<12GPL/ML). 
 The study was approved by the ethical committee of our hospital and 
informed consent was obtained from all the patients included in the study.  
Results of IgG and IgM  in cases and controls groups were statistically 
analysed using software SPSS version. Statistical  analysis of continuous 
data were made using student t test. A  p  value of less than 0.05 was 
considered significant. 
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30 cases and 30 
controls 
Slit lamp 
examination 
Echocardiography 
Measure 
Anticardiolipin 
antibody 
Correlate 
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CASE SHEET PROFORMA: 
Name: 
Age: 
Sex: 
Address: 
Presenting complaints: 
H/o Presenting illness: 
Past History: 
1)Diabetes Mellitus 
2)Hypertension  
3)long term use of drugs 
Systemic Examination: 
Blood pressure- 
Blood sugar- 
Ocular Examination: 
Visual acuity- 
  *Best corrected- 
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  *Near Vision- 
Eyelids and adnexa- 
Conjunctiva- 
Cornea- 
Anterior Chamber- 
Iris- 
Pupil- 
Lens- 
Extraocular movements- 
Posterior segment examination- 
 *Ophthalmoscopy-  
Central corneal thickness by ultrasound pachymetrys: 
  Slit lamp examination: 
                Applanation tonometry 
                Gonioscopy                                   
 Investigations: 
a) Echocardiography 
52 
 
b) Anticardiolipin antibody-  
    IgG 
                                      IgM  
 
  
53 
 
OBSERVATIONS AND RESULTS 
Age distribution  
Among the 30 patients who  were enrolled in the study all the  patients were 
more than 55 years of age and the average age  of the patients was 63.82 years . 
Table 1: Age distribution in pseudoexfoliation:  
AGE IN 
YEARS 
 
NO OF 
PATIENTS 
 
PERCENTAGE 
           ≥ 50 0 0 
51-60 9 30 
61-70 18 60 
71-80 3 10 
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Sex distribution 
Of the 30 patients, 15 patients were males (50%) and the remaining 15 patients 
were females (50%) 
Bar diagram 1: Sex distribution 
 
 
 
 
Laterality of pseudoexfoliation 
 (56.6%) of the thirty cases included in the study had unilateral 
pseudoexfoliation and the rest 13 (43.4%) had bilateral presentation. Hence the 
number of eyes with pseudoexfoliation is 43. 
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Distribution of pseudoexfoliation material 
 18 patients  in the pupillary marg
 9 patients in the anterior surface 
 3 patients in the iris and 
                      Pie chart showing distribution of PEX material
 
 
 
 
 
 
 
Pseudoexfoliation  in gonioscopy
Of the 43 eyes with pseudoexfoliation 34
trabecular meshwork and the remaining 9 (20.9%)  had normal pigmentation.
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Distribution of PEX material
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Pseudoexfoliaton and central corneal thickness 
The average central corneal thickness in eyes with pseudoexfoliation was  
498.04mm 
The average Central corneal thickness in eyes without pseudoexfoliation was 
486.75 mm 
BAR DIAGRAM 2:  CENTRAL CORNEAL THICKNESS 
 
Pseudoexfoliation and Intraocularpressure 
All the patients had  intraocular pressure in  the range of 12.3 ± 2.00 mmHg.  
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Pseudoexfoliation and antiphospholipid antibody
The  anticardiolipin antibody (acl)
diagram 3: 
The mean value of anticardiolipin IgG levels in pseudoexfoliation and controls  
groups were 7.35 and 3.20 
Mean ± standard error of anticardiolipin antibody IgG levels in patients with 
Pseudoexfoliation were significantly higher than those of the controls (p <0.05)
The acl IgG concentrations above the cut off value of 12GpL
in 10 of 30 patients (33.33%
The mean value of acl IgM  levels in patients with PEX and controls were 5.47 
and 5.06 . Anticardiolpin  IgM levels were found to be higher in patients with 
PEX than in the control groups. (p value < 0.01).
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-U/ml were found 
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acl IgG
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The level of anticardiolipin IgG and IgM  was found normal in the control 
groups.  
Statistical data of Anticardiolipin antibody levels: 
Mean           Cases 
 
        Controls 
 
P value 
 
acl IgG         7.35          3.20 <0.05 
acl IgM         5.47           5.06 <0.01 
 
Anticardiolipin 
 
CASES CONTROLS              t       P value 
MEAN SD MEAN SD 
           IgG        
 
7.35 4.18 5.06 2.30           2.62       <0.05 
            IgM        5.47 3.11 3.20 1.54           3.59        <0.01  
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Discussion: 
Age and Sex distribution in pseudoexfoliation: 
In the study conducted by Tarek A Shazly in Egypt , a population based study 
,the prevalence of PEX syndrome increased progressively after 50 years.4% of 
cases between 40-49 years,45% between 60-69 years,59% between 70-79 
years,11% between 80-89 years,2% between 90-99 years12. 
In another prospective  Hospital based study by Rashad Q Rao  in Pakistan ,the 
mean age of patients with pseudoexfoliation was 72.2 years. The prevalence 
was 2.6% in patients less than 70 years of age and increased to 13.04% in over 
70 years of age13. 
All the above studies showed  that pseudoexfoliation  significantly increases 
with age above 50 years. 
In this study 60% of cases were between 61-70 years of age, 30% were between 
51-60 years, and the remaining 10% between 71-80 years of age. 
Also this study consisted of 50% males and 50% females. All the studies 
showed no significance difference in sex predilection14. 
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Laterality  
Aravind et al in the study with 108 patients found that 53 (49.1%) had unilateral 
disease and bilateral in 55 (50.9%)15. 
Tarek A Shazly, reviewed records of 372 patients with PEX determined that 
82.2% of cases had bilateral pseudoexfoliation12. 
Many studies showed that pseudoexfoliation was bilateral disease, which 
initially had unilateral presentation and subsequently bilateral involvement later 
after few months to years16. 
In a study conducted by Parekh et al, 32 Patients of unilateral pseudoexfoliation  
was screened by using transmission electron microscopy of conjunctival 
specimens and anterior lens capsule was obtained during cataract surgery. He  
concluded that there  was  a 81%  chances of getting  PEX  in the unaffected eye 
ultrastructurally. 
In present study 56.6% of cases showed unilateral involvement and 43.4% of 
cases had bilateral disease. 
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Distribution of pseudoexfoliation material: 
According to a study by Thomas et al pseudoexfoliation was present in 
pupillary margin in 38 eyes (33.9%), on the lens in 71 eyes(63.4%), both 
locations  in 26 eyes(23.2%) and in the  trabecular meshwork in 1 eye (0.9%)17. 
 
According to a study by Rao VA and Kaliaperumal S, 95% of  PEX syndrome 
can be successfully  diagnosed  prior to dilatation by the presence of PEX 
material in the pupillary ruff. In 18%  of cases the material was found in 
pupillary ruff and  in  
100 % found in zone 3 or the peripheral band after dilatation. 
 
In this study 18 eyes (60%) had in pupillary margin, 9 eyes (30%) on the lens 
after pupillary dilatation, and in both locations in 3 eyes(10%). 
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Pseudoexfoliation in Gonioscopy and intraocular pressure: 
Aravind et al concluded that out of 108 patients with pseudoexfoliation,18 cases 
(16.7%) had high intraocular pressure (>21mmHg),16 cases (14.8%) had 
occludable angles, and 14 cases (13%) had pseudoexfoliative glaucoma15. 
Almost all studies showed PEX has been associated with raised intraocular 
pressure and glaucoma. 
Kozart and Yanoff, in a clinical based study of 100 consecutive patients with 
Pseudoexfoliation, reported 15% prevalence of ocular hypertension and 7% 
prevalence of glaucoma, however raised intraocular pressure was  due to PXF 
material blocking the trabecular meshwork causing open angle glaucoma and 
zonular weakness  resulting anterior movement of the lens, increased 
adhesiveness of the iris to the lens leading  to closed angle glaucoma18. 
In the present study of the 43 eyes with pseudoexfoliation 34 eyes   had(79%) 
darkly pigmented trabecular meshwork and the remaining 9 eyes (20.9%) had 
normal pigmentation. None of the patients had glaucoma. 
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Pseudoexfoliation and central corneal thickness: 
A.C Ventura et al studied central corneal thickness with normal tension 
glaucoma, POAG, pseudoexfoliative glaucoma, ocular hypertension and in 
controls. The  mean CCT  was higher in patients with OHT than in normal 
individuals , however there was no significant differences between the later four 
groups19. 
Hepsen et al measured  central corneal thickness in eyes with pseudoexfoliation 
syndrome and they found that the mean Central corneal thickness was not 
statistically significant compared to the controls, but the mean CCT in PEX 
glaucoma was significantly reduced when compared to normotensive PEX 
eyes20. 
Here the average CCT in eyes with PEX was 498.04mm and in controls was 
486.75mm  revealing  no significant change from normal CCT. 
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PSEUDOEXFOLIATION AND ANTIPHOSPHOLIPID ANTIBODY:  
In this study , we found elevated serum levels of anticardiolipin (IgG and IgM) 
in patients with pseudoexfoliation than in  controls. The increase in mean levels 
of acl IgG and IgM level in  patients with pseudoexfoliation were statistically 
significant. 
Antiphospholipid antibodies were originally described in Systemic Lupus 
Erythematosus. Later, these antibodies were also found in the absence of a 
systemic autoimmune disorder21. 
Recently published data showed raised anticardiolipin antibodies results in 
thrombosis through a variety of prothrombotic mechanism including endothelial 
dysfunction, platelet and fibrinolytic activation.  
Some studies suggest that PXS has been   associated with cardiovascular and 
cerebrovascular disease and thrombotic ocular complications like  central retinal  
artery occlusions. 
Tsakiris et al, found no significant difference between anticardiolipin levels in  
patients with normal tension glaucoma and POAG and controls22. 
Latalska et al, evaluated antiphospholipid antibodies in serum and aqueous 
humour in 19 patients with POAG, 18 with POAG, and 11 with PEXG. Plasma 
and aqueous fluid are collected and IgG , IgM were measured using ELISA 
method. The significant differences  were observed in levels of IgG in serum 
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(p=0.014) and in levels of IgM antibodies in aqueous humor (p=0.013) between 
glaucoma and non glaucoma patients23. 
Another similar prospective study conducted in Turkey included 15 patients 
with Primary open angle glaucoma , 17 patients with pseudoexfoliation 
syndrome,19 patients with pseudoexfoliative glaucoma ,and 19  healthy 
controls. Antiphospholipid antibodies were measured by ELISA assay. Lupus 
anticoagulant antibodies were measured by  using dilute russel viper venom 
time screen test. It was found that the anticardiolipin antibody IgG levels were 
significantly higher in patients with PXS,PXG than in POAG and controls (p < 
0.007). However acl IgM levels in PXS, PXG and POAG was higher but was 
not statistically significant. The p values were 0.160, 0.106, 0.747 and 0.610 
respectively. Lupus anticoagulant antibody levels of  pseudoexfoliation patients 
and controls were not statistically significant5.  
 
 From  this study  they concluded that elevated levels of serum anticardiolipin 
antibodies is a risk factor for cardiovascular and cerebrovascular disease in 
patients with pseudoexfoliation syndrome and pseudoexfoliative glaucoma 
compared to controls and POAG. The known pathophysiological role of 
anticardiolipin in pseudoexfoliative  patients are oxidative stress, apoptosis, 
endothelial dysfunction and  platelet activation5 . 
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  The  present study  included 30 patients with pseudoexfoliation and 30 healthy 
age matched controls. Echocardiography  was performed. All the patients had 
normal left ventricular diastole.  Antiphospholipid antibody  were measured by 
ELISA method in both study and control groups. 
The mean anticardiolipin  antibody IgG  levels in patients with PEX was 
significantly higher than in control groups (p value<0.05) and the mean value of 
anticardiolipin  antibody IgM was also significantly different between cases and 
controls (p value<0.01).  Both IgG and IgM levels were higher in 
pseudoexfoliation than in controls. 
Although echocardiography showed normal left ventricular function in all 
patients with pseudoexfoliation,  anticardiolipin antibody IgG and IgM was 
found higher in 10  out of 30 patients with pseudoexfoliation. These patients can 
go for cardiovascular risk later in their life, due to  probable adverse effects of  
elevated anticardiolipin antibodies on the endothelium. 
In our study, we could not find  any ocular associations  and anticardiolipin 
antibody. 
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Conclusion  
1)This study concluded  that elevated levels of anticardiolipin antibody in 
patients with pseudoexfoliation. 
2)Endothelial dysfunction has an important contributory role in 
pseudoexfoliation  and  increased anticardiolipin antibodies, with  thrombosis 
due to endothelial dysfunction being  the causative factor for adverse 
cardiovascular events in patients with pseudoexfoliation. 
3)  Anticardiolipin antibodies may be an  independent factor to evaluate the risk 
of  cardiovascular diseases in  pseudoexfoliation .  
4) Hence the attending ophthalmologist will be able to intimate the attending 
physician about the possible cardiac  risk association. 
  5) Further larger scale studies are needed to elucidate the role of  elevated   
anticardiolipin antibodies in pseudoexfoliation. 
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Limitations: 
 This study was performed in a small number  of patients. 
 We did not get any patients with  pseudoexfoliative glaucoma  during this 
period of the study.  
 Anticardiolipin antibodies has to be done in two occasions to confirm the 
diagnosis 
 Our results should be confirmed by large studies. 
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        SUMMARY 
INTRODUCTION: 
Pseudoexfoliation is characterised by the widespread deposition of whitish flaky 
material adherent to ocular and extraocular tissues. Among  extraocular tissue 
pseudoexfoliative fibres  are seen in heart, lungs, skin, gallbladder, 
bloodvessles. In present years pseudoexfoliation has been shown to be a 
systemic process associated with  cardiovascular disease. 
AIMS AND OBJECTIVES: 
PRIMARY AIM: 
1)  To evaluate the levels of anticardiolipin antibodies in patients with 
pseudoexfoliation and controls. 
 2) To assess the association between pseudoexfoliation and cardiovascular 
disease. 
Secondary Objective 
 1) To study the ocular diseases  associated with pseudoexfoliation. 
        2) To correlate between ocular diseases and anticardiolipin antibody. 
MATERIAL AND METHODS: This   is a  prospective study to  evaluate the 
levels of anticardiolipin antibody in patients with pseudoexfoliation. This study 
included 30 patients with pseudoexfoliation and 30 healthly controls with 
comparable age and gender with no comorbities.  
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All patients underwent  a complete ophthalmic examination , after  PXS was 
diagnosed. Echocardiography was done to know the cardiovascular status of the 
patients in 2 groups. 
 Serum anticardiolipin   antibodies IgG and IgM was done by using ELISA 
method in both cases and control groups. 
 
Observations: 
 We found elevated serum levels of anticardiolipin (IgG and IgM) antibody in 
patients with pseudoexfoliation. The mean level of acl IgG and IgM level in  
patients with pseudoexfoliation were statistically significant. 
Conclusions: 
Elevated levels of anticardiolipin antibody is a risk factor for cardiovascular 
problems . Hence the attending ophthalmologist will be able to intimate the 
attending physician about the possible cardiac  risk association 
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CASE SHEET 1: 
Name: Mr.Murugesan 
Age: 68 
Sex: Male 
Address: 
Presenting complaints: C/O defective vision in the left eye for past 6months 
H/o Presenting illness: Defective vision in left eye ,progressive in nature 
Past History: 
1)Diabetes Mellitus: NOT A K/C/O diabetic 
2)Hypertension: not a k/c/o Hypertensive  
3)long term use of drugs: NIL 
Systemic Examination: 
Blood pressure- 110/80 mmHg 
Blood sugar: 98 g/dl 
 
Ocular Examination: 
• Visual acuity- 
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  *Best corrected- RE-6/18                LE-PL+ 
  *Near Vision- N36 
• Eyelids and adnexa- NORMAL 
• Conjunctiva-CLEAR 
• Cornea-CLEAR 
• Anterior Chamber- NORMAL IN DEPTH 
• Iris-COLOR AND PATTERN NORMAL 
• Pupil-3 MM REACTING TO LIGHT 
• Lens-RE-NS4 
                   LE-MATURE CATARACT  
• Extraocular movements-FULL 
• Posterior segment examination 
 *Ophthalmoscopy- RE-DISC AND VESSELS NORMAL 
                                         MACULA- NORMAL 
• Central  Corneal Thickness: RE-515 
                                                         LE-518 
• Slit lamp examination: 
                PSEUDOEXFOLIATION IN THE PUPILLARY BORDER IN 
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BOTH EYES  
• Applanation tonometry:RE-14 
                                                  LE-12 
• GONIOSCOPY:RE                           LE               
                                                                                                                                           
• Investigations: 
A) ECHO- NORMAL LV FUNCTION. 
B) Anticardiolipin antibody: 
                    Ig G -12.9GPL/Ml 
                     Ig M-2.9GPL/Ml 
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CASE SHEET 2: 
Name: MRS- THULASIAMMAL 
Age: 62 
Sex: FEMALE 
Address: 
Presenting complaints: C/O defective vision in the both eyes for past  1 year 
                                  c/o watering in the both eyes   
H/o Presenting illness: Defective vision in  both eyes ,progressive in nature 
Past History: 
1)Diabetes Mellitus: NOT A K/C/O diabetic 
2)Hypertension: not a k/c/o Hypertensive  
3)long term use of drugs: NIL 
Systemic Examination: 
Blood pressure- 120/80 mmHg 
Blood sugar: 110 g/dl 
Ocular Examination: 
Visual acuity- 
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  *Best corrected- RE-HM 
                                             LE-1/60 
  *Near Vision- N36 
Eyelids and adnexa- NORMAL 
Conjunctiva-CLEAR 
Cornea-CLEAR 
Anterior Chamber- NORMAL IN DEPTH 
Iris-COLOR AND PATTERN NORMAL 
Pupil-3 MM REACTING TO LIGHT 
Lens-RE- MATURE CATRACT 
        LE- IMMATURE CATARACT,NS4  
Extraocular movements-FULL 
Posterior segment examination 
 *Ophthalmoscopy- RE- media was hazy due to catarct 
                                       LE-  DISC AND VESSELS NORMAL 
                                               MACULA- DRUSEN + 
CENTRAL CORNEALTHICKNESS: 
80 
 
                                RE-510 
                               LE-512   
  Slit lamp examination: 
                PSEUDOEXFOLIATION IN THE  ANTERIOR SURFACE OF THE 
LENS AND IN PUPILLARY BORDER IN RIGHT EYE  
                Applanation tonometry: 
                                                   RE-15 
                                                   LE-12 
 
 
 
GONIOSCOPY:RE                       LE                                   
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 Investigations: 
A) ECHO- NORMAL LV FUNCTION. 
B) Anticardiolipin antibody: 
                    Ig G -12.9GPL/Ml 
                     Ig M-10.2GPL/Ml5                                                 
 
CASE SHEET 3: 
Name: MR KARUPPAN 
Age:  59 
Sex: MALE 
Address: 
Presenting complaints: C/O defective vision in the both eyes for past 6 months                       
H/o Presenting illness: Defective vision in  both eyes ,progressive in nature 
                                 c/o itching in right eye    
Past History: 
1)Diabetes Mellitus: NOT A K/C/O diabetic 
2)Hypertension: not a k/c/o Hypertensive  
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3)long term use of drugs: NIL 
Systemic Examination: 
Blood pressure- 120/90 mmHg 
Blood sugar: 116 g/dl 
Ocular Examination: 
Visual acuity- 
  *Best corrected- RE-1/60 
                                             LE-1/60 
  *Near Vision- N60 
Eyelids and adnexa- NORMAL 
Conjunctiva-CLEAR 
Cornea-CLEAR 
Anterior Chamber- NORMAL IN DEPTH 
Iris-COLOR AND PATTERN NORMAL 
Pupil-4 MM  ROUND  REACTING TO LIGHT 
Lens-RE- IMMATURE CATRACT,NS4 
        LE- IMMATURE CATARACT,NS4  
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Extraocular movements-FULL 
Posterior segment examination 
 *Ophthalmoscopy- RE- media was hazy due to catarct 
                                       BE-  DISC  NORMAL 
                                         
CENTRAL CORNEALTHICKNESS: 
                                RE-512 
                               LE-511  
  Slit lamp examination: 
                PSEUDOEXFOLIATION IN THE  ANTERIOR SURFACE OF THE 
LENS AND IN PUPILLARY BORDER IN RIGHT EYE  
                Applanation tonometry:RE-10 
                                                   LE-12 
GONIOSCOPY:RE                       LE                                   
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TRABECULAR PIGMENTATION DARK IN RIGHT EYE 
                                                                                     
 Investigations: 
A) ECHO- NORMAL  
B) Anticardiolipin antibody: 
                    Ig G -12.GPL/Ml 
                     Ig M- 2.0GPL/Ml 
 
 
CASE SHEET 4: 
Name: MRS.KALIYAMMAL 
Age:  55 
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Sex: FEMALE 
Address: 
Presenting complaints: C/O defective vision in the both eyes for past 6 months 
                            
H/o Presenting illness: Defective vision in  both eyes ,progressive in nature 
                                  
Past History: 
1)Diabetes Mellitus: NOT A K/C/O diabetic 
2)Hypertension: not a k/c/o Hypertensive  
3)long term use of drugs: NIL 
Systemic Examination: 
Blood pressure- 130/90 mmHg 
Blood sugar: 120 g/dl 
Ocular Examination: 
Visual acuity- 
  *Best corrected- RE- CFCF 
                                             LE-6/24 
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  *Near Vision- N60 
Eyelids and adnexa- NORMAL 
Conjunctiva-CLEAR 
Cornea-CLEAR, NEBULLA + 
Anterior Chamber- NORMAL IN DEPTH 
Iris-COLOR AND PATTERN NORMAL 
Pupil-3 MM  ROUND  REACTING TO LIGHT 
Lens-RE- MATURE CATRACT 
        LE- IMMATURE CATARACT,NS2 
Extraocular movements-FULL 
Posterior segment examination 
 *Ophthalmoscopy- RE- media was hazy due to catarct 
                                       LE-  DISC AND VESSELS   NORMAL 
                                               MACULA -FOVEAL REFLEX + 
                                               
CENTRAL CORNEALTHICKNESS: 
                                RE-498 
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                               LE-493 
  Slit lamp examination: 
                PSEUDOEXFOLIATION IN THE  ANTERIOR SURFACE OF THE 
LENS  IN BOTH EYES  
                Applanation tonometry:RE-17 
                                                   LE-17 
GONIOSCOPY:RE                       LE                                   
  
              
                                                                                          
 Investigations: 
A) ECHO- NORMAL  
B) Anticardiolipin antibody: 
                    Ig G -12.1GPL/Ml 
                     Ig M- 2.0GPL/ML                                   
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NAME  
OP NUMBER 
 
AGE 
SEX 
 
VISUAL 
ACUITY 
  
CATARACT 
 
 
PXF ZONES 
    
ANGLES 
 
GONIOSCOPY 
TRABECULAR 
PIGMENTATION 
 
 
INTRA 
OCULAR 
PRESSURE 
CENTRAL 
CORNEAL 
THICKNESS 
   
 
APLA 
 
1.MURUGASEN 
O12/044170 
68/M 6/18 PL NS4 MC IRIS IRIS OPEN OPEN DARK DARK 14 12 515 518 12.9 2.9 
 
2.THULASIAMMAL 
O11090323 
62/F 6/9 6/36 PCIOL NS3  LENS OPEN OPEN N N 10 8 507 498 2.9 3.0 
 
3.THIRUGNANAM 
O12058266 
85/M 6/24 6/36 NS3 NS3 IRIS IRIS OPEN OPEN DARK DARK 18 16 607 620 5.1 4.3 
 
4.ARUNACHALAM 
O12054608 
64/M 6/12 6/18 PCIOL NS2 IRIS IRIS OPEN OPEN DARK DARK 16 16 473 478 1.7 4.3 
 
5.RAMAL 
O12062085 
80/F HM I/60 MC NS4 IRIS 
LENS 
 OPEN OPEN DARK  15 12 510 512 12.9 10.2 
 
6.RAMASAMY 
O12062081 
60/M 1/60 6/60 NS4 NS3 LENS LENS OPEN OPEN N N 12 10 493 495 2.4 3.8 
 
7.THIRUVENKATASAMY 
O12032031 
68/M 6/36 6/24 NS3 NS3 IRIS IRIS OPEN OPEN DARK DARK 18 18 496 510 9.3 4.5 
 
8.DEVARAJAN 
O12065085 
60/M CFCF 6/18 MC PCIOL  LENS OPEN OPEN  DARK 15 11 505 508 6.2 2.1 
 
9.KARUPPAN 
O00009760 
 
59/M 1/60 1/60 NS4 NS4 IRIS 
LENS 
 OPEN OPEN DARK  10 12 512 511 12.0 2.0 
 
10.ANANDHALAKSHMI 
O12070286 
88/F HM 6/60 MC NS3 IRIS IRIS OPEN OPEN DARK  DARK 18 16 523 524 3.4 3.4 
 
11.VALLIAMMAL 
O12070284 
 
65/F 
6/18 3/60 PCIOL NS4  LENS OPEN OPEN N N 12 11 515 512 2.8 2.8 
12.RAJAMMAL 
O12070645 
 
68/F 6/60 6/36 PCIOL NS3  LENS OPEN OPEN DARK DARK 12 12 498 493 4.1 2.2 
13.KANTHATHAL 
O12072629 
55/F 6/60 6/18 NS3 NS3 IRIS  OPEN OPEN DARK  18 10 510 512 4.3 5.5 
14.DHANDAPANI 
 
61/M 4/60 4/60 NS4 NS4  IRIS OEN OPEN  DARK 10 10 513 518 11.0 7.9 
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NAMES 
 
AGE 
SEX 
 
VISUAL ACUITY 
  
CATARACT 
 
 
PXF ZONES 
    
ANGLES 
 
GONIOSCOPY 
TRABECULAR 
PIGMENTATION 
 
 
INTRA 
OCULAR 
PRESSURE 
 
CENTRAL 
CORNEAL 
THICKNESS 
   
 
APLA 
 
15.SUNDARAM 
O12075491 
64/m 6/12 6/12 Ns2 Ns2 
 
Iris Iris Dark Dark Open Open 14 14 495 501 6.6 6.0 
 
16.KALIYAMMAL 
O12083994 
55/F CFCF 6/24 MC NS2 LENS LENS N N OPEN  OPEN 
 
17 17 498 493 12.1 2.0 
 
17.SUSEELA 
O12084258 
55/F 6/36P 6/36 PSC PSC IRIS IRIS DARK DARK OPEN OPEN 17 16 495 501 3.0 2.3 
 
18.NAGAMMAL 
O13012492 
60/F PL+ 6/6 MC PCIOL IRIS 
LENS 
- DARK  OPEN OPEN 12 14 481 483 12.9 2.9 
 
19.MARY 
O13013726 
70/F 6/12 6/18P NS2 NS2 IRIS - - - OPEN OPEN 12 16 495 501 6.1 5.3 
 
20.AMARAVATHY 
O13013514 
69/F 6/24 6/9 NS2 PCIOL IRIS  - - OPEN OPEN 11 10 511 519 12.3 9.0 
21.KOMARASAMY 
O11088348 
 
71/M 6/36P 3/60 PCIOL NS4 LENS - DARK DARK OPEN OPEN 10 12 505 509 12 12 
22.MAYILSAMY 
I13012663 
 
60/M 6/12 2/60 PCIOL NS4 IRIS IRIS DARK DARK OPEN OPEN 17 16 510 512 3.2 9.0 
23.KANNAMMAL 
I13017198 
 
70/M HM 6/60 MC NS3 IRIS IRIS DARK DARK OPEN OPEN 10 12 499 503 4.9 5.0 
24.GOPALAN 
O13041753 
 
70/M 6/12 6/9 PCIOL PCIOL IRIS - N N OPEN OPEN 12 14 512 514 12 12 
25.PRABUKARAN 
O13044610 
 
60/M 6/9 6/9 NS1 NS1 IRIS IRIS DARK DARK OPEN OPEN 15 15 502 504 6.0 6.6 
26.SUNDARI 
O03022514 
59/F 6/24 6/24 PCIOL PCIOL IRIS - N N OPEN OPEN 13 12 555 555 4.5 9.3 
27.VALIAMMAL 60/F 6/36 6/24 PCIOL PCIOL IRIS IRIS DARK DARK OPEN OPEN 12 12 514 515 12.9 10.2 
28.BALAKRISHNAN 
O13000838 
 
62/M 6/24 6/9 NS2 PCIOL LENS  N N OPEN OPEN 10 11 540 556 12.9 2.9 
29.BALASUBRAMANIAN 
O12076377 
62/M 6/18 6/18 PCIOL PCIOL IRIS IRIS DARK DARK OPEN OPEN 14 14 540 555 4.1 2.2 
30.LAKSHMIIAMMAL 
O09040037 
 
56/F 6/60 6/60 NS2 NS2 LENS LENS DARK DARK OPEN OPEN 17 16 560 555 2.8 2.8 
